{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:54:26Z","timestamp":1790787266310,"version":"4.1.0"},"reference-count":118,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T00:00:00Z","timestamp":1679961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T00:00:00Z","timestamp":1679961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s00109-023-02308-5","type":"journal-article","created":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T02:02:42Z","timestamp":1679968962000},"page":"487-500","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["The role of hypoxia-inducible factor 1\u03b1 in hepatic lipid metabolism"],"prefix":"10.1007","volume":"101","author":[{"given":"Mingxiao","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2501-9299","authenticated-orcid":false,"given":"Tingting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6818-9212","authenticated-orcid":false,"given":"Haiquan","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,28]]},"reference":[{"key":"2308_CR1","doi-asserted-by":"publisher","unstructured":"Hirode G, Saab S, Wong R (2020) Trends in the burden of chronic liver disease among hospitalized US adults. JAMA network open 3(4):e201997. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.1997","DOI":"10.1001\/jamanetworkopen.2020.1997"},{"issue":"3","key":"2308_CR2","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1136\/gutjnl-2019-318813","volume":"69","author":"Z Younossi","year":"2020","unstructured":"Younossi Z, Stepanova M, Younossi Y, Golabi P, Mishra A, Rafiq N, Henry L (2020) Epidemiology of chronic liver diseases in the USA in the past three decades. Gut 69(3):564\u2013568. https:\/\/doi.org\/10.1136\/gutjnl-2019-318813","journal-title":"Gut"},{"issue":"3","key":"2308_CR3","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","volume":"70","author":"Z Younossi","year":"2019","unstructured":"Younossi Z (2019) Non-alcoholic fatty liver disease - a global public health perspective. J Hepatol 70(3):531\u2013544. https:\/\/doi.org\/10.1016\/j.jhep.2018.10.033","journal-title":"J Hepatol"},{"issue":"1","key":"2308_CR4","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jhep.2019.03.004","volume":"71","author":"J Xiao","year":"2019","unstructured":"Xiao J, Wang F, Wong N, He J, Zhang R, Sun R, Xu Y, Liu Y, Li W, Koike K et al (2019) Global liver disease burdens and research trends: analysis from a Chinese perspective. J Hepatol 71(1):212\u2013221. https:\/\/doi.org\/10.1016\/j.jhep.2019.03.004","journal-title":"J Hepatol"},{"issue":"1","key":"2308_CR5","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1038\/s41598-022-05168-0","volume":"12","author":"A Farrell","year":"2022","unstructured":"Farrell A, Magliano D, Shaw J, Thompson A, Croagh C, Ryan M, Howell J (2022) A problem of proportions: estimates of metabolic associated fatty liver disease and liver fibrosis in Australian adults in the nationwide 2012 AusDiab Study. Sci Rep 12(1):1956. https:\/\/doi.org\/10.1038\/s41598-022-05168-0","journal-title":"Sci Rep"},{"issue":"2","key":"2308_CR6","first-page":"1092","volume":"14","author":"E Ryu","year":"2022","unstructured":"Ryu E, Xia H, Guo G, Zhang L (2022) Multivariable-adjusted trends in mortality due to alcoholic liver disease among adults in the United States, from 1999\u20132017. Am J Transl Res 14(2):1092\u20131099","journal-title":"Am J Transl Res"},{"key":"2308_CR7","doi-asserted-by":"publisher","unstructured":"Heeren J, Scheja L (2021) Metabolic-associated fatty liver disease and lipoprotein metabolism. Mol Metab 50:101238. https:\/\/doi.org\/10.1016\/j.molmet.2021.101238","DOI":"10.1016\/j.molmet.2021.101238"},{"issue":"7","key":"2308_CR8","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","volume":"158","author":"M Eslam","year":"2020","unstructured":"Eslam M, Sanyal A, George J (2020) MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology 158(7):1999-2014.e1991. https:\/\/doi.org\/10.1053\/j.gastro.2019.11.312","journal-title":"Gastroenterology"},{"key":"2308_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-022-07434-7","author":"C Aniemeka","year":"2022","unstructured":"Aniemeka C, Pillai A (2022) HCC mortality trends-in with ALD (and NAFLD) and out with HCV. Dig Dis Sci. https:\/\/doi.org\/10.1007\/s10620-022-07434-7","journal-title":"Dig Dis Sci"},{"issue":"1","key":"2308_CR10","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/s42003-020-01367-5","volume":"3","author":"J Seo","year":"2020","unstructured":"Seo J, Jeong D, Park J, Lee K, Fukuda J, Chun Y (2020) Fatty-acid-induced FABP5\/HIF-1 reprograms lipid metabolism and enhances the proliferation of liver cancer cells. Communi Biol 3(1):638. https:\/\/doi.org\/10.1038\/s42003-020-01367-5","journal-title":"Communi Biol"},{"key":"2308_CR11","doi-asserted-by":"publisher","unstructured":"Huang Y, Lian W, Wang F, Wang P, Lin H, Tsai M, Yang Y (2022) HIF-1\u03b1MiR-29a curbs hepatocellular carcinoma incidence via targeting of HIF-1\u03b1 and ANGPT2. Int J Mol Sci 23(3). https:\/\/doi.org\/10.3390\/ijms23031636","DOI":"10.3390\/ijms23031636"},{"key":"2308_CR12","doi-asserted-by":"publisher","first-page":"11960","DOI":"10.1038\/ncomms11960","volume":"7","author":"X Gao","year":"2016","unstructured":"Gao X, Lin S, Ren F, Li J, Chen J, Yao C, Yang H, Jiang S, Yan G, Wang D et al (2016) Acetate functions as an epigenetic metabolite to promote lipid synthesis under hypoxia. Nat Commun 7:11960. https:\/\/doi.org\/10.1038\/ncomms11960","journal-title":"Nat Commun"},{"issue":"3","key":"2308_CR13","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.jhep.2016.04.010","volume":"65","author":"S Sundaram","year":"2016","unstructured":"Sundaram S, Halbower A, Pan Z, Robbins K, Capocelli K, Klawitter J, Shearn C, Sokol R (2016) Nocturnal hypoxia-induced oxidative stress promotes progression of pediatric non-alcoholic fatty liver disease. J Hepatol 65(3):560\u2013569. https:\/\/doi.org\/10.1016\/j.jhep.2016.04.010","journal-title":"J Hepatol"},{"key":"2308_CR14","doi-asserted-by":"publisher","unstructured":"de la Rosa Rodriguez M, Deng L, Gemmink A, van Weeghel M, Aoun M, Warnecke C, Singh R, Borst J, Kersten S (2021) Hypoxia-inducible lipid droplet-associated induces DGAT1 and promotes lipid storage in hepatocytes. Mol Metab 47:101168. https:\/\/doi.org\/10.1016\/j.molmet.2021.101168","DOI":"10.1016\/j.molmet.2021.101168"},{"issue":"4","key":"2308_CR15","doi-asserted-by":"publisher","first-page":"901","DOI":"10.2337\/db06-0911","volume":"56","author":"N Hosogai","year":"2007","unstructured":"Hosogai N, Fukuhara A, Oshima K, Miyata Y, Tanaka S, Segawa K, Furukawa S, Tochino Y, Komuro R, Matsuda M et al (2007) Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 56(4):901\u2013911. https:\/\/doi.org\/10.2337\/db06-0911","journal-title":"Diabetes"},{"key":"2308_CR16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/978-1-4419-1241-1_10","volume":"662","author":"K Kondo","year":"2010","unstructured":"Kondo K, Sugioka T, Tsukada K, Aizawa M, Takizawa M, Shimizu K, Morimoto M, Suematsu M, Goda N (2010) Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, improves hepatic microcirculatory patency and oxygen availability in a high-fat-diet-induced fatty liver in mice. Adv Exp Med Biol 662:77\u201382. https:\/\/doi.org\/10.1007\/978-1-4419-1241-1_10","journal-title":"Adv Exp Med Biol"},{"key":"2308_CR17","doi-asserted-by":"publisher","unstructured":"Sun J, Zhao L, Wu H, Liu Q, Liao L, Luo J, Lian W, Cui C, Jin L, Ma J et al (2020) Acute hypoxia changes the mode of glucose and lipid utilization in the liver of the largemouth bass (Micropterus salmoides). Sci Total Environ 713:135157. https:\/\/doi.org\/10.1016\/j.scitotenv.2019.135157","DOI":"10.1016\/j.scitotenv.2019.135157"},{"issue":"12","key":"2308_CR18","doi-asserted-by":"publisher","first-page":"5447","DOI":"10.1128\/mcb.12.12.5447-5454.1992","volume":"12","author":"G Semenza","year":"1992","unstructured":"Semenza G, Wang G (1992) A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 12(12):5447\u20135454. https:\/\/doi.org\/10.1128\/mcb.12.12.5447-5454.1992","journal-title":"Mol Cell Biol"},{"key":"2308_CR19","doi-asserted-by":"publisher","unstructured":"Wang S, Song J, Yang Y, Zhang Y, Wang H, Ma J (2015) HIF3A DNA methylation is associated with childhood obesity and ALT. PloS One 10(12):e0145944. https:\/\/doi.org\/10.1371\/journal.pone.0145944","DOI":"10.1371\/journal.pone.0145944"},{"key":"2308_CR20","doi-asserted-by":"publisher","unstructured":"Mandl M, Lieberum M, Depping R (2016) A HIF-1\u03b1-driven feed-forward loop augments HIF signalling in Hep3B cells by upregulation of ARNT. Cell Death Dis 7(6):e2284. https:\/\/doi.org\/10.1038\/cddis.2016.187","DOI":"10.1038\/cddis.2016.187"},{"key":"2308_CR21","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1146\/annurev-pathol-012513-104720","volume":"9","author":"G Semenza","year":"2014","unstructured":"Semenza G (2014) Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology. Annu Rev Pathol 9:47\u201371. https:\/\/doi.org\/10.1146\/annurev-pathol-012513-104720","journal-title":"Annu Rev Pathol"},{"issue":"5516","key":"2308_CR22","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1126\/science.1059796","volume":"292","author":"P Jaakkola","year":"2001","unstructured":"Jaakkola P, Mole D, Tian Y, Wilson M, Gielbert J, Gaskell S, von Kriegsheim A, Hebestreit H, Mukherji M, Schofield C et al (2001) Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science (New York, NY) 292(5516):468\u2013472. https:\/\/doi.org\/10.1126\/science.1059796","journal-title":"Science (New York, NY)"},{"issue":"5","key":"2308_CR23","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.cmet.2010.03.001","volume":"11","author":"N Zhang","year":"2010","unstructured":"Zhang N, Fu Z, Linke S, Chicher J, Gorman J, Visk D, Haddad G, Poellinger L, Peet D, Powell F et al (2010) The asparaginyl hydroxylase factor inhibiting HIF-1alpha is an essential regulator of metabolism. Cell Metab 11(5):364\u2013378. https:\/\/doi.org\/10.1016\/j.cmet.2010.03.001","journal-title":"Cell Metab"},{"issue":"2","key":"2308_CR24","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.jcmgh.2021.03.011","volume":"12","author":"R Mooli","year":"2021","unstructured":"Mooli R, Rodriguez J, Takahashi S, Solanki S, Gonzalez F, Ramakrishnan S, Shah Y (2021) Hypoxia via ERK signaling inhibits hepatic PPAR\u03b1 to promote fatty liver. Cell Mol Gastroenterol Hepatol 12(2):585\u2013597. https:\/\/doi.org\/10.1016\/j.jcmgh.2021.03.011","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"10","key":"2308_CR25","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1111\/liv.14519","volume":"40","author":"E Rey","year":"2020","unstructured":"Rey E, Mel\u00e9ndez-Rodr\u00edguez F, Mara\u00f1\u00f3n P, Gil-Valle M, Carrasco A, Torres-Capelli M, Ch\u00e1vez S, Del Pozo-Maroto E, Rodr\u00edguez de C\u00eda J, Aragon\u00e9s J et al (2020) Hypoxia-inducible factor 2\u03b1 drives hepatosteatosis through the fatty acid translocase CD36. Liver Int\u202f: Official J Int Assoc Study Liver 40(10):2553\u20132567. https:\/\/doi.org\/10.1111\/liv.14519","journal-title":"Liver Int : Official J Int Assoc Study Liver"},{"key":"2308_CR26","doi-asserted-by":"publisher","unstructured":"Holzner L, Murray A (2021) Hypoxia-inducible factors as key players in the pathogenesis of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Frontiers in medicine 8:753268. https:\/\/doi.org\/10.3389\/fmed.2021.753268","DOI":"10.3389\/fmed.2021.753268"},{"issue":"1","key":"2308_CR27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41574-018-0096-z","volume":"15","author":"F Gonzalez","year":"2018","unstructured":"Gonzalez F, Xie C, Jiang C (2018) The role of hypoxia-inducible factors in metabolic diseases. Nat Rev Endocrinol 15(1):21\u201332. https:\/\/doi.org\/10.1038\/s41574-018-0096-z","journal-title":"Nat Rev Endocrinol"},{"key":"2308_CR28","doi-asserted-by":"publisher","first-page":"24618","DOI":"10.1038\/srep24618","volume":"6","author":"A Thomas","year":"2016","unstructured":"Thomas A, Belaidi E, Aron-Wisnewsky J, van der Zon G, Levy P, Clement K, Pepin J, Godin-Ribuot D, Guigas B (2016) Hypoxia-inducible factor prolyl hydroxylase 1 (PHD1) deficiency promotes hepatic steatosis and liver-specific insulin resistance in mice. Sci Rep 6:24618. https:\/\/doi.org\/10.1038\/srep24618","journal-title":"Sci Rep"},{"issue":"5","key":"2308_CR29","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1172\/jci23621","volume":"115","author":"K Donnelly","year":"2005","unstructured":"Donnelly K, Smith C, Schwarzenberg S, Jessurun J, Boldt M, Parks E (2005) Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Investig 115(5):1343\u20131351. https:\/\/doi.org\/10.1172\/jci23621","journal-title":"J Clin Investig"},{"key":"2308_CR30","doi-asserted-by":"publisher","unstructured":"Wang C, Liu H, Chang Z, Huang T, Lee T (2021) Losartan prevents hepatic steatosis and macrophage polarization by inhibiting HIF-1\u03b1 in a murine model of NAFLD. Int J Mol Sci 22(15). https:\/\/doi.org\/10.3390\/ijms22157841","DOI":"10.3390\/ijms22157841"},{"key":"2308_CR31","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.cbi.2018.02.025","volume":"285","author":"H Jin","year":"2018","unstructured":"Jin H, Lian N, Bian M, Zhang C, Chen X, Shao J, Wu L, Chen A, Guo Q, Zhang F et al (2018) Oroxylin A prevents alcohol-induced hepatic steatosis through inhibition of hypoxia inducible factor 1alpha. Chem Biol Interact 285:14\u201320. https:\/\/doi.org\/10.1016\/j.cbi.2018.02.025","journal-title":"Chem Biol Interact"},{"key":"2308_CR32","doi-asserted-by":"publisher","unstructured":"Yan Y, Wu X, Wang P, Zhang S, Sun L, Zhao Y, Zeng G, Liu B, Xu G, Liu H et al (2020) Homocysteine promotes hepatic steatosis by activating the adipocyte lipolysis in a HIF1\u03b1-ERO1\u03b1-dependent oxidative stress manner. Redox Biol 37:101742. https:\/\/doi.org\/10.1016\/j.redox.2020.101742","DOI":"10.1016\/j.redox.2020.101742"},{"key":"2308_CR33","doi-asserted-by":"publisher","unstructured":"Wang Z, Li B, Jiang H, Ma Y, Bao Y, Zhu X, Xia H, Jin Y (2021) IL-8 exacerbates alcohol-induced fatty liver disease via the Akt\/HIF-1\u03b1 pathway in human IL-8-expressing mice. Cytokine 138:155402. https:\/\/doi.org\/10.1016\/j.cyto.2020.155402","DOI":"10.1016\/j.cyto.2020.155402"},{"key":"2308_CR34","doi-asserted-by":"publisher","unstructured":"Prasun P, Ginevic I, Oishi K (2021) Mitochondrial dysfunction in nonalcoholic fatty liver disease and alcohol related liver disease.\u00a0Transl Gastroenterol Hepatol 6:4. https:\/\/doi.org\/10.21037\/tgh-20-125","DOI":"10.21037\/tgh-20-125"},{"issue":"6","key":"2308_CR35","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.7150\/thno.63824","volume":"12","author":"L Xu","year":"2022","unstructured":"Xu L, Huang Z, Lo T, Lee J, Yang R, Yan X, Ye D, Xu A, Wong C (2022) Hepatic PRMT1 ameliorates diet-induced hepatic steatosis via induction of PGC1\u03b1. Theranostics 12(6):2502\u20132518. https:\/\/doi.org\/10.7150\/thno.63824","journal-title":"Theranostics"},{"issue":"1","key":"2308_CR36","doi-asserted-by":"publisher","first-page":"18367","DOI":"10.1038\/s41598-020-75615-3","volume":"10","author":"E Goetzman","year":"2020","unstructured":"Goetzman E, Bharathi S, Zhang Y, Zhao X, Dobrowolski S, Peasley K, Sims-Lucas S, Monga S (2020) Impaired mitochondrial medium-chain fatty acid oxidation drives periportal macrovesicular steatosis in sirtuin-5 knockout mice. Sci Rep 10(1):18367. https:\/\/doi.org\/10.1038\/s41598-020-75615-3","journal-title":"Sci Rep"},{"issue":"2","key":"2308_CR37","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.toxlet.2014.01.033","volume":"226","author":"Y Liu","year":"2014","unstructured":"Liu Y, Ma Z, Zhao C, Wang Y, Wu G, Xiao J, McClain C, Li X, Feng W (2014) HIF-1\u03b1 and HIF-2\u03b1 are critically involved in hypoxia-induced lipid accumulation in hepatocytes through reducing PGC-1\u03b1-mediated fatty acid \u03b2-oxidation. Toxicol Lett 226(2):117\u2013123. https:\/\/doi.org\/10.1016\/j.toxlet.2014.01.033","journal-title":"Toxicol Lett"},{"key":"2308_CR38","doi-asserted-by":"publisher","unstructured":"Wei S, Liu S, Su X, Wang W, Li F, Deng J, Lyu Y, Geng B, Xu G (2018) Spontaneous development of hepatosteatosis in perilipin-1 null mice with adipose tissue dysfunction. Biochimica et biophysica acta. Mol Cell Biol Lipids 1863(2):212\u2013218. https:\/\/doi.org\/10.1016\/j.bbalip.2017.11.007","DOI":"10.1016\/j.bbalip.2017.11.007"},{"issue":"17","key":"2308_CR39","doi-asserted-by":"publisher","first-page":"4073","DOI":"10.1111\/bph.12765","volume":"171","author":"X Dou","year":"2014","unstructured":"Dou X, Xia Y, Chen J, Qian Y, Li S, Zhang X, Song Z (2014) Rectification of impaired adipose tissue methylation status and lipolytic response contributes to hepatoprotective effect of betaine in a mouse model of alcoholic liver disease. Br J Pharmacol 171(17):4073\u20134086. https:\/\/doi.org\/10.1111\/bph.12765","journal-title":"Br J Pharmacol"},{"issue":"9","key":"2308_CR40","doi-asserted-by":"publisher","first-page":"6240","DOI":"10.1074\/jbc.M111.299115","volume":"287","author":"J Deng","year":"2012","unstructured":"Deng J, Liu S, Zou L, Xu C, Geng B, Xu G (2012) Lipolysis response to endoplasmic reticulum stress in adipose cells. J Biol Chem 287(9):6240\u20136249. https:\/\/doi.org\/10.1074\/jbc.M111.299115","journal-title":"J Biol Chem"},{"issue":"1","key":"2308_CR41","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2337\/db09-0942","volume":"59","author":"E Arner","year":"2010","unstructured":"Arner E, Westermark P, Spalding K, Britton T, Ryd\u00e9n M, Fris\u00e9n J, Bernard S, Arner P (2010) Adipocyte turnover: relevance to human adipose tissue morphology. Diabetes 59(1):105\u2013109. https:\/\/doi.org\/10.2337\/db09-0942","journal-title":"Diabetes"},{"issue":"5","key":"2308_CR42","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1128\/mcb.00951-12","volume":"33","author":"K Sun","year":"2013","unstructured":"Sun K, Halberg N, Khan M, Magalang U, Scherer P (2013) Selective inhibition of hypoxia-inducible factor 1\u03b1 ameliorates adipose tissue dysfunction. Mol Cell Biol 33(5):904\u2013917. https:\/\/doi.org\/10.1128\/mcb.00951-12","journal-title":"Mol Cell Biol"},{"key":"2308_CR43","doi-asserted-by":"publisher","unstructured":"Jo H, Choe S, Shin K, Jang H, Lee J, Seong J, Back S, Kim J (2013) Endoplasmic reticulum stress induces hepatic steatosis via increased expression of the hepatic very low-density lipoprotein receptor. Hepatology (Baltimore, Md.) 57(4):1366\u20131377. https:\/\/doi.org\/10.1002\/hep.26126","DOI":"10.1002\/hep.26126"},{"issue":"4","key":"2308_CR44","doi-asserted-by":"publisher","first-page":"200","DOI":"10.5551\/jat.11.200","volume":"11","author":"S Takahashi","year":"2004","unstructured":"Takahashi S, Sakai J, Fujino T, Hattori H, Zenimaru Y, Suzuki J, Miyamori I, Yamamoto T (2004) The very low-density lipoprotein (VLDL) receptor: characterization and functions as a peripheral lipoprotein receptor. J Atheroscler Thromb 11(4):200\u2013208. https:\/\/doi.org\/10.5551\/jat.11.200","journal-title":"J Atheroscler Thromb"},{"issue":"1","key":"2308_CR45","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12964-020-00640-8","volume":"18","author":"E Barroso","year":"2020","unstructured":"Barroso E, Rodr\u00edguez-Rodr\u00edguez R, Zarei M, Pizarro-Degado J, Planavila A, Palomer X, Villarroya F, V\u00e1zquez-Carrera M (2020) SIRT3 deficiency exacerbates fatty liver by attenuating the HIF1\u03b1-LIPIN 1 pathway and increasing CD36 through Nrf2. Cell Commun Signal 18(1):147. https:\/\/doi.org\/10.1186\/s12964-020-00640-8","journal-title":"Cell Commun Signal"},{"issue":"2","key":"2308_CR46","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1042\/bj20111377","volume":"441","author":"G Shen","year":"2012","unstructured":"Shen G, Zhao Y, Chen M, Zhang F, Liu X, Wang Y, Liu C, Yu J, Zhang J (2012) Hypoxia-inducible factor-1 (HIF-1) promotes LDL and VLDL uptake through inducing VLDLR under hypoxia. Biochem J 441(2):675\u2013683. https:\/\/doi.org\/10.1042\/bj20111377","journal-title":"Biochem J"},{"issue":"5","key":"2308_CR47","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1002\/path.4494","volume":"235","author":"T Na","year":"2015","unstructured":"Na T, Han Y, Ka N, Park H, Kang Y, Kwon S, Lee B, Lee M (2015) 22-S-Hydroxycholesterol protects against ethanol-induced liver injury by blocking the auto\/paracrine activation of MCP-1 mediated by LXR\u03b1. J Pathol 235(5):710\u2013720. https:\/\/doi.org\/10.1002\/path.4494","journal-title":"J Pathol"},{"issue":"5","key":"2308_CR48","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3760\/cma.j.issn.1007-3418.2014.05.010","volume":"22","author":"Z Sun","year":"2014","unstructured":"Sun Z, Shen W (2014) Effect of intermittent hypoxia on lipid metabolism in liver cells and the underlying mechanism. Chinese J Hepatol 22(5):369\u2013373. https:\/\/doi.org\/10.3760\/cma.j.issn.1007-3418.2014.05.010","journal-title":"Chinese J Hepatol"},{"key":"2308_CR49","doi-asserted-by":"publisher","unstructured":"Yang B, Sun J, Liang S, Wu P, Lv R, He Y, Li D, Sun W, Song X (2021) Prediction of Srebp-1 as a key target of Qing Gan San against MAFLD in rats via RNA-sequencing profile analysis. Front Pharmacol 12:680081. https:\/\/doi.org\/10.3389\/fphar.2021.680081","DOI":"10.3389\/fphar.2021.680081"},{"issue":"6","key":"2308_CR50","doi-asserted-by":"publisher","first-page":"3410","DOI":"10.1039\/c9fo00284g","volume":"10","author":"C Zhang","year":"2019","unstructured":"Zhang C, Hu J, Sheng L, Yuan M, Wu Y, Chen L, Wang G, Qiu Z (2019) Ellagic acid ameliorates AKT-driven hepatic steatosis in mice by suppressing de novo lipogenesis via the AKT\/SREBP-1\/FASN pathway. Food Funct 10(6):3410\u20133420. https:\/\/doi.org\/10.1039\/c9fo00284g","journal-title":"Food Funct"},{"issue":"41","key":"2308_CR51","doi-asserted-by":"publisher","first-page":"11468","DOI":"10.1021\/acs.jafc.0c05077","volume":"68","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Ma D, Wang H, Li M, Talukder M, Wang H, Li J (2020) Lycopene prevents DEHP-induced liver lipid metabolism disorder by inhibiting the HIF-1\u03b1-induced PPAR\u03b1\/PPAR\u03b3\/FXR\/LXR system. J Agric Food Chem 68(41):11468\u201311479. https:\/\/doi.org\/10.1021\/acs.jafc.0c05077","journal-title":"J Agric Food Chem"},{"key":"2308_CR52","doi-asserted-by":"publisher","unstructured":"Minniti M, Pedrelli M, Vedin L, Delb\u00e8s A, Denis R, \u00d6\u00f6rni K, Sala C, Pirazzini C, Thiagarajan D, Nurmi H et al (2020) Insights from liver-humanized mice on cholesterol lipoprotein metabolism and LXR-agonist pharmacodynamics in humans. Hepatology (Baltimore, Md.) 72(2):656\u2013670. https:\/\/doi.org\/10.1002\/hep.31052","DOI":"10.1002\/hep.31052"},{"issue":"1","key":"2308_CR53","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1038\/s41467-017-01965-8","volume":"8","author":"W Du","year":"2017","unstructured":"Du W, Zhang L, Brett-Morris A, Aguila B, Kerner J, Hoppel C, Puchowicz M, Serra D, Herrero L, Rini B et al (2017) HIF drives lipid deposition and cancer in ccRCC via repression of fatty acid metabolism. Nat Commun 8(1):1769. https:\/\/doi.org\/10.1038\/s41467-017-01965-8","journal-title":"Nat Commun"},{"issue":"6","key":"2308_CR54","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1016\/j.celrep.2014.08.028","volume":"8","author":"LT Huang","year":"2014","unstructured":"Huang LT, Li X, Zhang L, Sun L, He X, Zhong X, Jia D, Song L, Semenza G et al (2014) HIF-1-mediated suppression of acyl-CoA dehydrogenases and fatty acid oxidation is critical for cancer progression. Cell Rep 8(6):1930\u20131942. https:\/\/doi.org\/10.1016\/j.celrep.2014.08.028","journal-title":"Cell Rep"},{"key":"2308_CR55","doi-asserted-by":"publisher","unstructured":"Tolwani R, Hamm D, Tian L, Sharer J, Vockley J, Rinaldo P, Matern D, Schoeb T, Wood P (2005) Medium-chain acyl-CoA dehydrogenase deficiency in gene-targeted mice. PLoS Genetics 1(2):e23. https:\/\/doi.org\/10.1371\/journal.pgen.0010023","DOI":"10.1371\/journal.pgen.0010023"},{"key":"2308_CR56","doi-asserted-by":"publisher","unstructured":"Sheridan R, Lampe K, Shanmukhappa S, Putnam P, Keddache M, Divanovic S, Bezerra J, Hoebe K (2011) Lampe1: an ENU-germline mutation causing spontaneous hepatosteatosis identified through targeted exon-enrichment and next-generation sequencing. PloS One 6(7):e21979. https:\/\/doi.org\/10.1371\/journal.pone.0021979","DOI":"10.1371\/journal.pone.0021979"},{"issue":"4","key":"2308_CR57","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1172\/jci17305","volume":"112","author":"A Norris","year":"2003","unstructured":"Norris A, Chen L, Fisher S, Szanto I, Ristow M, Jozsi A, Hirshman M, Rosen E, Goodyear L, Gonzalez F et al (2003) Muscle-specific PPARgamma-deficient mice develop increased adiposity and insulin resistance but respond to thiazolidinediones. J Clin Investig 112(4):608\u2013618. https:\/\/doi.org\/10.1172\/jci17305","journal-title":"J Clin Investig"},{"issue":"2","key":"2308_CR58","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s13105-021-00791-3","volume":"77","author":"R Ezzeddini","year":"2021","unstructured":"Ezzeddini R, Taghikhani M, Salek Farrokhi A, Somi M, Samadi N, Esfahani A, Rasaee M (2021) Downregulation of fatty acid oxidation by involvement of HIF-1\u03b1 and PPAR\u03b3 in human gastric adenocarcinoma and related clinical significance. J Physiol Biochem 77(2):249\u2013260. https:\/\/doi.org\/10.1007\/s13105-021-00791-3","journal-title":"J Physiol Biochem"},{"key":"2308_CR59","doi-asserted-by":"publisher","unstructured":"Iesari S, Leclercq I, Joudiou N, Komuta M, Daumerie A, Ambroise J, Dili A, Feza-Bingi N, Xhema D, Bouzin C et al (2021) Selective HIF stabilization alleviates hepatocellular steatosis and ballooning in a rodent model of 70% liver resection. Clin Sci (London, England : 1979) 135(19):2285\u20132305. https:\/\/doi.org\/10.1042\/cs20210183","DOI":"10.1042\/cs20210183"},{"key":"2308_CR60","doi-asserted-by":"publisher","unstructured":"Mi X, Li Z, Yan J, Li Y, Zheng J, Zhuang Z, Yang W, Gong L, Shi J (2020) Activation of HIF-1 signaling ameliorates liver steatosis in zebrafish atp7b deficiency (Wilson\u2019s disease) models. Biochimica et biophysica acta. Mol Basis Dis\u00a01866(10):165842. https:\/\/doi.org\/10.1016\/j.bbadis.2020.165842","DOI":"10.1016\/j.bbadis.2020.165842"},{"key":"2308_CR61","doi-asserted-by":"publisher","unstructured":"Qu A, Taylor M, Xue X, Matsubara T, Metzger D, Chambon P, Gonzalez F, Shah Y (2011) Hypoxia-inducible transcription factor 2\u03b1 promotes steatohepatitis through augmenting lipid accumulation, inflammation, and fibrosis. Hepatology (Baltimore, Md.) 54(2):472\u2013483. https:\/\/doi.org\/10.1002\/hep.24400","DOI":"10.1002\/hep.24400"},{"key":"2308_CR62","doi-asserted-by":"publisher","first-page":"41038","DOI":"10.1038\/srep41038","volume":"7","author":"J Wang","year":"2017","unstructured":"Wang J, Lu Z, Xu Z, Tian P, Miao H, Pan S, Song R, Sun X, Zhao B, Wang D et al (2017) Reduction of hepatic fibrosis by overexpression of von Hippel-Lindau protein in experimental models of chronic liver disease. Sci Rep 7:41038. https:\/\/doi.org\/10.1038\/srep41038","journal-title":"Sci Rep"},{"issue":"16","key":"2308_CR63","doi-asserted-by":"publisher","first-page":"4527","DOI":"10.1128\/mcb.00200-09","volume":"29","author":"E Rankin","year":"2009","unstructured":"Rankin E, Rha J, Selak M, Unger T, Keith B, Liu Q, Haase V (2009) Hypoxia-inducible factor 2 regulates hepatic lipid metabolism. Mol Cell Biol 29(16):4527\u20134538. https:\/\/doi.org\/10.1128\/mcb.00200-09","journal-title":"Mol Cell Biol"},{"issue":"11","key":"2308_CR64","doi-asserted-by":"publisher","first-page":"3790","DOI":"10.1128\/mcb.01580-07","volume":"28","author":"L Lei","year":"2008","unstructured":"Lei L, Mason S, Liu D, Huang Y, Marks C, Hickey R, Jovin I, Pypaert M, Johnson R, Giordano F (2008) Hypoxia-inducible factor-dependent degeneration, failure, and malignant transformation of the heart in the absence of the von Hippel-Lindau protein. Mol Cell Biol 28(11):3790\u20133803. https:\/\/doi.org\/10.1128\/mcb.01580-07","journal-title":"Mol Cell Biol"},{"issue":"11","key":"2308_CR65","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1016\/j.febslet.2012.04.039","volume":"586","author":"K Schulz","year":"2012","unstructured":"Schulz K, Milke L, R\u00fcbsamen D, Menrad H, Schmid T, Br\u00fcne B (2012) HIF-1\u03b1 protein is upregulated in HIF-2\u03b1 depleted cells via enhanced translation. FEBS Lett 586(11):1652\u20131657. https:\/\/doi.org\/10.1016\/j.febslet.2012.04.039","journal-title":"FEBS Lett"},{"key":"2308_CR66","doi-asserted-by":"publisher","unstructured":"Liao M, Li Y, Xiao A, Lu Q, Zeng H, Qin H, Zheng E, Luo X, Chen L, Ruan X et al (2022) HIF-2\u03b1-induced upregulation of CD36 promotes the development of ccRCC. Exp Cell Res 421(2):113389. https:\/\/doi.org\/10.1016\/j.yexcr.2022.113389","DOI":"10.1016\/j.yexcr.2022.113389"},{"issue":"4","key":"2308_CR67","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1210\/clinem\/dgz266","volume":"105","author":"C Hu","year":"2019","unstructured":"Hu C, Hoene M, Plomgaard P, Hansen JS, Zhao X, Li J, Wang X, Clemmesen JO, Secher NH, H\u00e4ring HU et al (2019) Muscle-liver substrate fluxes in exercising humans and potential effects on hepatic metabolism. J Clin Endocrinol Metab 105(4):1196\u20131209. https:\/\/doi.org\/10.1210\/clinem\/dgz266","journal-title":"J Clin Endocrinol Metab"},{"key":"2308_CR68","doi-asserted-by":"publisher","unstructured":"Laitakari A, Ollonen T, Kietzmann T, Walkinshaw G, Mennerich D, Izzi V, Haapasaari K, Myllyharju J, Serpi R, Dimova E et al (2019) Systemic inactivation of hypoxia-inducible factor prolyl 4-hydroxylase 2 in mice protects from alcohol-induced fatty liver disease. Redox Biol 22:101145. https:\/\/doi.org\/10.1016\/j.redox.2019.101145","DOI":"10.1016\/j.redox.2019.101145"},{"issue":"10","key":"2308_CR69","doi-asserted-by":"publisher","first-page":"3324","DOI":"10.2337\/db14-0472","volume":"63","author":"L Rahtu-Korpela","year":"2014","unstructured":"Rahtu-Korpela L, Karsikas S, H\u00f6rkk\u00f6 S, Blanco Sequeiros R, Lammentausta E, M\u00e4kel\u00e4 K, Herzig K, Walkinshaw G, Kivirikko K, Myllyharju J et al (2014) HIF prolyl 4-hydroxylase-2 inhibition improves glucose and lipid metabolism and protects against obesity and metabolic dysfunction. Diabetes 63(10):3324\u20133333. https:\/\/doi.org\/10.2337\/db14-0472","journal-title":"Diabetes"},{"issue":"2","key":"2308_CR70","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.jhep.2011.07.024","volume":"56","author":"Y Nishiyama","year":"2012","unstructured":"Nishiyama Y, Goda N, Kanai M, Niwa D, Osanai K, Yamamoto Y, Senoo-Matsuda N, Johnson R, Miura S, Kabe Y et al (2012) HIF-1\u03b1 induction suppresses excessive lipid accumulation in alcoholic fatty liver in mice. J Hepatol 56(2):441\u2013447. https:\/\/doi.org\/10.1016\/j.jhep.2011.07.024","journal-title":"J Hepatol"},{"issue":"1","key":"2308_CR71","doi-asserted-by":"publisher","first-page":"14230","DOI":"10.1038\/s41598-018-32586-w","volume":"8","author":"T Arai","year":"2018","unstructured":"Arai T, Tanaka M, Goda N (2018) HIF-1-dependent lipin1 induction prevents excessive lipid accumulation in choline-deficient diet-induced fatty liver. Sci Rep 8(1):14230. https:\/\/doi.org\/10.1038\/s41598-018-32586-w","journal-title":"Sci Rep"},{"issue":"12","key":"2308_CR72","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1016\/j.ajpath.2018.08.003","volume":"188","author":"M Strowitzki","year":"2018","unstructured":"Strowitzki M, Kirchberg J, Tuffs C, Schiedeck M, Ritter A, Biller M, Harnoss J, Lasitschka F, Schmidt T, Radhakrishnan P et al (2018) Loss of prolyl-hydroxylase 1 protects against biliary fibrosis via attenuated activation of hepatic stellate cells. Am J Pathol 188(12):2826\u20132838. https:\/\/doi.org\/10.1016\/j.ajpath.2018.08.003","journal-title":"Am J Pathol"},{"key":"2308_CR73","doi-asserted-by":"publisher","unstructured":"Strowitzki M, Ritter A, Kimmer G, Schneider M (2019) Hypoxia-adaptive pathways: a pharmacological target in fibrotic disease? Pharmacol Res 147:104364. https:\/\/doi.org\/10.1016\/j.phrs.2019.104364","DOI":"10.1016\/j.phrs.2019.104364"},{"key":"2308_CR74","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.2147\/dmso.s246949","volume":"13","author":"M Sepehrimanesh","year":"2020","unstructured":"Sepehrimanesh M, Niknam R, Ejtehadi F, Fattahi M, Safarpour A (2020) Association between non-alcoholic fatty liver disease and metabolic syndrome with gallstone disease, South Iran: a population-based study. Diabetes Metab Syndr Obes\u202f: Targets Ther 13:1449\u20131458. https:\/\/doi.org\/10.2147\/dmso.s246949","journal-title":"Diabetes Metab Syndr Obes : Targets Ther"},{"issue":"1","key":"2308_CR75","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s12944-020-01402-8","volume":"19","author":"B Sheng","year":"2020","unstructured":"Sheng B, Zhao Q, Ma M, Zhang J (2020) An inverse association of weight and the occurrence of asymptomatic gallbladder stone disease in hypercholesterolemia patients: a case-control study. Lipids Health Dis 19(1):228. https:\/\/doi.org\/10.1186\/s12944-020-01402-8","journal-title":"Lipids Health Dis"},{"issue":"11","key":"2308_CR76","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/j.hpb.2020.07.011","volume":"22","author":"I Rodr\u00edguez-Antonio","year":"2020","unstructured":"Rodr\u00edguez-Antonio I, L\u00f3pez-S\u00e1nchez G, Garrido-Camacho V, Uribe M, Ch\u00e1vez-Tapia N, Nu\u00f1o-L\u00e1mbarri N (2020) Cholecystectomy as a risk factor for non-alcoholic fatty liver disease development. HPB (Oxford) 22(11):1513\u20131520. https:\/\/doi.org\/10.1016\/j.hpb.2020.07.011","journal-title":"HPB (Oxford)"},{"key":"2308_CR77","doi-asserted-by":"publisher","unstructured":"Larocca M, Soria L, Espelt M, Lehmann G, Marinelli R (2009) Knockdown of hepatocyte aquaporin-8 by RNA interference induces defective bile canalicular water transport. American journal of physiology. Gastrointest Liver Physiol 296(1):G93\u2013100. https:\/\/doi.org\/10.1152\/ajpgi.90410.2008","DOI":"10.1152\/ajpgi.90410.2008"},{"issue":"6","key":"2308_CR78","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1053\/j.gastro.2017.01.001","volume":"152","author":"Y Asai","year":"2017","unstructured":"Asai Y, Yamada T, Tsukita S, Takahashi K, Maekawa M, Honma M, Ikeda M, Murakami K, Munakata Y, Shirai Y et al (2017) Activation of the hypoxia inducible factor 1\u03b1 subunit pathway in steatotic liver contributes to formation of cholesterol gallstones. Gastroenterology 152(6):1521-1535.e1528. https:\/\/doi.org\/10.1053\/j.gastro.2017.01.001","journal-title":"Gastroenterology"},{"issue":"2","key":"2308_CR79","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jus.2012.02.009","volume":"15","author":"M Giordani","year":"2012","unstructured":"Giordani M, Giaretta R, Scolarin C, Stefani M, Pellizzari C, Tamarozzi F, Brunetti E (2012) Ultrasound and infections on the Tibetan Plateau(). J Ultrasound 15(2):83\u201392. https:\/\/doi.org\/10.1016\/j.jus.2012.02.009","journal-title":"J Ultrasound"},{"issue":"1","key":"2308_CR80","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/j.1572-0241.1999.00787.x","volume":"94","author":"P Moro","year":"1999","unstructured":"Moro P, Checkley W, Gilman R, Lescano G, Bonilla J, Silva B, Garcia H (1999) Gallstone disease in high-altitude Peruvian rural populations. Am J Gastroenterol 94(1):153\u2013158. https:\/\/doi.org\/10.1111\/j.1572-0241.1999.00787.x","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"2308_CR81","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.cmet.2018.01.007","volume":"27","author":"X Ouyang","year":"2018","unstructured":"Ouyang X, Han S, Zhang J, Dioletis E, Nemeth B, Pacher P, Feng D, Bataller R, Cabezas J, St\u00e4rkel P et al (2018) Digoxin suppresses pyruvate kinase M2-promoted HIF-1\u03b1 transactivation in steatohepatitis. Cell Metab 27(2):339-350.e333. https:\/\/doi.org\/10.1016\/j.cmet.2018.01.007","journal-title":"Cell Metab"},{"key":"2308_CR82","doi-asserted-by":"publisher","unstructured":"Stroeve J, Brufau G, Stellaard F, Gonzalez F, Staels B, Kuipers F (2010) Intestinal FXR-mediated FGF15 production contributes to diurnal control of hepatic bile acid synthesis in mice. Lab Invest; A J Technical Methods Pathol 90(10):1457\u20131467. https:\/\/doi.org\/10.1038\/labinvest.2010.107","DOI":"10.1038\/labinvest.2010.107"},{"issue":"4","key":"2308_CR83","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1053\/j.gastro.2018.06.038","volume":"155","author":"A Al-Khaifi","year":"2018","unstructured":"Al-Khaifi A, Rudling M, Angelin B (2018) An FXR agonist reduces bile acid synthesis independently of increases in FGF19 in healthy volunteers. Gastroenterology 155(4):1012\u20131016. https:\/\/doi.org\/10.1053\/j.gastro.2018.06.038","journal-title":"Gastroenterology"},{"issue":"4","key":"2308_CR84","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1111\/liv.12456","volume":"35","author":"J Schmitt","year":"2015","unstructured":"Schmitt J, Kong B, Stieger B, Tschopp O, Schultze S, Rau M, Weber A, M\u00fcllhaupt B, Guo G, Geier A (2015) Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal. Liver Int\u202f: Official J Int Assoc Study Liver 35(4):1133\u20131144. https:\/\/doi.org\/10.1111\/liv.12456","journal-title":"Liver Int : Official J Int Assoc Study Liver"},{"issue":"6","key":"2308_CR85","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/s0092-8674(00)00062-3","volume":"102","author":"C Sinal","year":"2000","unstructured":"Sinal C, Tohkin M, Miyata M, Ward J, Lambert G, Gonzalez F (2000) Targeted disruption of the nuclear receptor FXR\/BAR impairs bile acid and lipid homeostasis. Cell 102(6):731\u2013744. https:\/\/doi.org\/10.1016\/s0092-8674(00)00062-3","journal-title":"Cell"},{"issue":"5","key":"2308_CR86","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1111\/j.1742-4658.2009.06867.x","volume":"276","author":"T Fujino","year":"2009","unstructured":"Fujino T, Murakami K, Ozawa I, Minegishi Y, Kashimura R, Akita T, Saitou S, Atsumi T, Sato T, Ando K et al (2009) Hypoxia downregulates farnesoid X receptor via a hypoxia-inducible factor-independent but p38 mitogen-activated protein kinase-dependent pathway. FEBS J 276(5):1319\u20131332. https:\/\/doi.org\/10.1111\/j.1742-4658.2009.06867.x","journal-title":"FEBS J"},{"key":"2308_CR87","doi-asserted-by":"publisher","unstructured":"Zhang P, Zheng L, Duan Y, Gao Y, Gao H, Mao D, Luo Y (2022) Gut microbiota exaggerates triclosan-induced liver injury via gut-liver axis. J Hazard Mater 421:126707. https:\/\/doi.org\/10.1016\/j.jhazmat.2021.126707","DOI":"10.1016\/j.jhazmat.2021.126707"},{"issue":"1","key":"2308_CR88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2021.1927633","volume":"13","author":"Y Rao","year":"2021","unstructured":"Rao Y, Kuang Z, Li C, Guo S, Xu Y, Zhao D, Hu Y, Song B, Jiang Z, Ge Z et al (2021) Gut Akkermansia muciniphila ameliorates metabolic dysfunction-associated fatty liver disease by regulating the metabolism of L-aspartate via gut-liver axis. Gut microbes 13(1):1\u201319. https:\/\/doi.org\/10.1080\/19490976.2021.1927633","journal-title":"Gut microbes"},{"issue":"12","key":"2308_CR89","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1136\/gutjnl-2012-303816","volume":"62","author":"T Le Roy","year":"2013","unstructured":"Le Roy T, Llopis M, Lepage P, Bruneau A, Rabot S, Bevilacqua C, Martin P, Philippe C, Walker F, Bado A et al (2013) Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice. Gut 62(12):1787\u20131794. https:\/\/doi.org\/10.1136\/gutjnl-2012-303816","journal-title":"Gut"},{"key":"2308_CR90","doi-asserted-by":"publisher","unstructured":"Liu X, Sun R, Li Z, Xiao R, Lv P, Sun X, Olson M, Gong Y (2021) Luteolin alleviates non-alcoholic fatty liver disease in rats via restoration of intestinal mucosal barrier damage and microbiota imbalance involving in gut-liver axis.\u00a0Arch Biochem Biophys\u00a0711:109019. https:\/\/doi.org\/10.1016\/j.abb.2021.109019","DOI":"10.1016\/j.abb.2021.109019"},{"issue":"9","key":"2308_CR91","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1084\/jem.193.9.1027","volume":"193","author":"G Furuta","year":"2001","unstructured":"Furuta G, Turner J, Taylor C, Hershberg R, Comerford K, Narravula S, Podolsky D, Colgan S (2001) Hypoxia-inducible factor 1-dependent induction of intestinal trefoil factor protects barrier function during hypoxia. J Exp Med 193(9):1027\u20131034. https:\/\/doi.org\/10.1084\/jem.193.9.1027","journal-title":"J Exp Med"},{"key":"2308_CR92","doi-asserted-by":"publisher","unstructured":"Zheng L, Kelly C, Colgan S (2015) Physiologic hypoxia and oxygen homeostasis in the healthy intestine. A review in the theme: cellular responses to hypoxia.\u00a0Am J Physiol Cell Physiol 309(6):C350\u2013360. https:\/\/doi.org\/10.1152\/ajpcell.00191.2015","DOI":"10.1152\/ajpcell.00191.2015"},{"issue":"12","key":"2308_CR93","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/nri.2017.103","volume":"17","author":"C Taylor","year":"2017","unstructured":"Taylor C, Colgan S (2017) Regulation of immunity and inflammation by hypoxia in immunological niches. Nat Rev Immunol 17(12):774\u2013785. https:\/\/doi.org\/10.1038\/nri.2017.103","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"2308_CR94","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/nrgastro.2010.39","volume":"7","author":"S Colgan","year":"2010","unstructured":"Colgan S, Taylor C (2010) Hypoxia: an alarm signal during intestinal inflammation. Nat Rev Gastroenterol Hepatol 7(5):281\u2013287. https:\/\/doi.org\/10.1038\/nrgastro.2010.39","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"2308_CR95","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.jhep.2018.05.021","volume":"69","author":"T Shao","year":"2018","unstructured":"Shao T, Zhao C, Li F, Gu Z, Liu L, Zhang L, Wang Y, He L, Liu Y, Liu Q et al (2018) Intestinal HIF-1\u03b1 deletion exacerbates alcoholic liver disease by inducing intestinal dysbiosis and barrier dysfunction. J Hepatol 69(4):886\u2013895. https:\/\/doi.org\/10.1016\/j.jhep.2018.05.021","journal-title":"J Hepatol"},{"issue":"5","key":"2308_CR96","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.chom.2015.03.005","volume":"17","author":"C Kelly","year":"2015","unstructured":"Kelly C, Zheng L, Campbell E, Saeedi B, Scholz C, Bayless A, Wilson K, Glover L, Kominsky D, Magnuson A et al (2015) Crosstalk between microbiota-derived short-chain fatty acids and intestinal epithelial HIF augments tissue barrier function. Cell Host Microbe 17(5):662\u2013671. https:\/\/doi.org\/10.1016\/j.chom.2015.03.005","journal-title":"Cell Host Microbe"},{"key":"2308_CR97","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s42003-019-0526-z","volume":"2","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Ran C, Ding Q, Liu H, Xie M, Yang Y, Xie Y, Gao C, Zhang H, Zhou Z (2019) Ability of prebiotic polysaccharides to activate a HIF1\u03b1-antimicrobial peptide axis determines liver injury risk in zebrafish. Commun Biol 2:274. https:\/\/doi.org\/10.1038\/s42003-019-0526-z","journal-title":"Commun Biol"},{"issue":"12","key":"2308_CR98","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1091\/mbc.E14-07-1194","volume":"26","author":"B Saeedi","year":"2015","unstructured":"Saeedi B, Kao D, Kitzenberg D, Dobrinskikh E, Schwisow K, Masterson J, Kendrick A, Kelly C, Bayless A, Kominsky D et al (2015) HIF-dependent regulation of claudin-1 is central to intestinal epithelial tight junction integrity. Mol Biol Cell 26(12):2252\u20132262. https:\/\/doi.org\/10.1091\/mbc.E14-07-1194","journal-title":"Mol Biol Cell"},{"issue":"5","key":"2308_CR99","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s00535-011-0374-1","volume":"46","author":"A Ria\u00f1o","year":"2011","unstructured":"Ria\u00f1o A, Ortiz-Masi\u00e0 D, Vel\u00e1zquez M, Calatayud S, Esplugues J, Barrachina M (2011) Nitric oxide induces HIF-1\u03b1 stabilization and expression of intestinal trefoil factor in the damaged rat jejunum and modulates ulcer healing. J Gastroenterol 46(5):565\u2013576. https:\/\/doi.org\/10.1007\/s00535-011-0374-1","journal-title":"J Gastroenterol"},{"key":"2308_CR100","doi-asserted-by":"publisher","unstructured":"Kim Y, Yi E, Kim Y, Lee A, Chung J, Ha H, Cho J, Kim S, Ko H, Cheon J et al (2020) Local stabilization of hypoxia-inducible factor-1\u03b1 controls intestinal inflammation via enhanced gut barrier function and immune regulation. Front Immunol 11:609689. https:\/\/doi.org\/10.3389\/fimmu.2020.609689","DOI":"10.3389\/fimmu.2020.609689"},{"issue":"6","key":"2308_CR101","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1038\/mi.2013.6","volume":"6","author":"C Kelly","year":"2013","unstructured":"Kelly C, Glover L, Campbell E, Kominsky D, Ehrentraut S, Bowers B, Bayless A, Saeedi B, Colgan S (2013) Fundamental role for HIF-1\u03b1 in constitutive expression of human \u03b2 defensin-1. Mucosal Immunol 6(6):1110\u20131118. https:\/\/doi.org\/10.1038\/mi.2013.6","journal-title":"Mucosal Immunol"},{"issue":"1","key":"2308_CR102","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s40168-021-01137-3","volume":"9","author":"S Foley","year":"2021","unstructured":"Foley S, Tuohy C, Dunford M, Grey M, De Luca H, Cawley C, Szabady R, Maldonado-Contreras A, Houghton J, Ward D et al (2021) Gut microbiota regulation of P-glycoprotein in the intestinal epithelium in maintenance of homeostasis. Microbiome 9(1):183. https:\/\/doi.org\/10.1186\/s40168-021-01137-3","journal-title":"Microbiome"},{"key":"2308_CR103","doi-asserted-by":"publisher","unstructured":"Fei N, Bruneau A, Zhang X, Wang R, Wang J, Rabot S, G\u00e9rard P, Zhao L (2020) Endotoxin producers overgrowing in human gut microbiota as the causative agents for nonalcoholic fatty liver disease. mBio 11(1). https:\/\/doi.org\/10.1128\/mBio.03263-19","DOI":"10.1128\/mBio.03263-19"},{"issue":"1","key":"2308_CR104","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1124\/jpet.114.219832","volume":"352","author":"P Zhang","year":"2015","unstructured":"Zhang P, Qiang X, Zhang M, Ma D, Zhao Z, Zhou C, Liu X, Li R, Chen H, Zhang Y (2015) Demethyleneberberine, a natural mitochondria-targeted antioxidant, inhibits mitochondrial dysfunction, oxidative stress, and steatosis in alcoholic liver disease mouse model. J Pharmacol Exp Ther 352(1):139\u2013147. https:\/\/doi.org\/10.1124\/jpet.114.219832","journal-title":"J Pharmacol Exp Ther"},{"key":"2308_CR105","doi-asserted-by":"publisher","unstructured":"Zheng Y, Huang C, Zhao L, Chen Y, Liu F (2021) Regulation of decorin by ursolic acid protects against non-alcoholic steatohepatitis. Biomed Pharmacother = Biomed Pharmacother 143:112166. https:\/\/doi.org\/10.1016\/j.biopha.2021.112166","DOI":"10.1016\/j.biopha.2021.112166"},{"key":"2308_CR106","doi-asserted-by":"publisher","unstructured":"Ma Z, Zhang Y, Li Q, Xu M, Bai J, Wu S (2017) Resveratrol improves alcoholic fatty liver disease by downregulating HIF-1\u03b1 expression and mitochondrial ROS production. PloS One 12(8):e0183426. https:\/\/doi.org\/10.1371\/journal.pone.0183426","DOI":"10.1371\/journal.pone.0183426"},{"issue":"2","key":"2308_CR107","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1093\/toxsci\/kfw228","volume":"155","author":"C Lu","year":"2017","unstructured":"Lu C, Xu W, Shao J, Zhang F, Chen A, Zheng S (2017) Nrf2 activation is required for ligustrazine to inhibit hepatic steatosis in alcohol-preferring mice and hepatocytes. Toxicol Sci\u202f: An Official J Soc Toxicol 155(2):432\u2013443. https:\/\/doi.org\/10.1093\/toxsci\/kfw228","journal-title":"Toxicol Sci : An Official J Soc Toxicol"},{"issue":"5","key":"2308_CR108","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/s0168-8278(02)00037-5","volume":"36","author":"Y Yang","year":"2002","unstructured":"Yang Y, Lin H, Huang Y, Lee T, Hou M, Lee F, Liu R, Chang F, Lee S (2002) Effect of 1-week losartan administration on bile duct-ligated cirrhotic rats with portal hypertension. J Hepatol 36(5):600\u2013606. https:\/\/doi.org\/10.1016\/s0168-8278(02)00037-5","journal-title":"J Hepatol"},{"key":"2308_CR109","doi-asserted-by":"publisher","unstructured":"Yang Y, Lee P, Huang Y, Lee W, Kuo Y, Lee K, Hsieh Y, Lee T, Lin H (2014) Involvement of the HIF-1\u03b1 and Wnt\/\u03b2-catenin pathways in the protective effects of losartan on fatty liver graft with ischaemia\/reperfusion injury. Clin Sci (London, England : 1979) 126(2):163\u2013174. https:\/\/doi.org\/10.1042\/cs20130025","DOI":"10.1042\/cs20130025"},{"key":"2308_CR110","doi-asserted-by":"publisher","unstructured":"Zhao P, Han S, Arumugam S, Yousaf M, Qin Y, Jiang J, Torok N, Chen Y, Mankash M, Liu J et al (2019) Digoxin improves steatohepatitis with differential involvement of liver cell subsets in mice through inhibition of PKM2 transactivation. American journal of physiology. Gastrointestinal Liver Physiol 317(4):G387-G397. https:\/\/doi.org\/10.1152\/ajpgi.00054.2019","DOI":"10.1152\/ajpgi.00054.2019"},{"issue":"5","key":"2308_CR111","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.cell.2011.03.054","volume":"145","author":"W Luo","year":"2011","unstructured":"Luo W, Hu H, Chang R, Zhong J, Knabel M, O\u2019Meally R, Cole R, Pandey A, Semenza G (2011) Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell 145(5):732\u2013744. https:\/\/doi.org\/10.1016\/j.cell.2011.03.054","journal-title":"Cell"},{"issue":"1","key":"2308_CR112","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1158\/1535-7163.mct-07-0463","volume":"7","author":"M Koh","year":"2008","unstructured":"Koh M, Spivak-Kroizman T, Venturini S, Welsh S, Williams R, Kirkpatrick D, Powis G (2008) Molecular mechanisms for the activity of PX-478, an antitumor inhibitor of the hypoxia-inducible factor-1alpha. Mol Cancer Ther 7(1):90\u2013100. https:\/\/doi.org\/10.1158\/1535-7163.mct-07-0463","journal-title":"Mol Cancer Ther"},{"key":"2308_CR113","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.atherosclerosis.2022.01.002","volume":"344","author":"N Villa-Roel","year":"2022","unstructured":"Villa-Roel N, Ryu K, Gu L, Fernandez Esmerats J, Kang D, Kumar S, Jo H (2022) Hypoxia inducible factor 1\u03b1 inhibitor PX-478 reduces atherosclerosis in mice. Atherosclerosis 344:20\u201330. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2022.01.002","journal-title":"Atherosclerosis"},{"key":"2308_CR114","doi-asserted-by":"publisher","unstructured":"Cho H, Kim H, Lee K, Lasli S, Ung A, Hoffman T, Nasiri R, Bandaru P, Ahadian S, Dokmeci M et al (2021) Bioengineered multicellular liver microtissues for modeling advanced hepatic fibrosis driven through non-alcoholic fatty liver disease. Small (Weinheim an der Bergstrasse, Germany) 17(14):e2007425. https:\/\/doi.org\/10.1002\/smll.202007425","DOI":"10.1002\/smll.202007425"},{"issue":"1","key":"2308_CR115","doi-asserted-by":"publisher","first-page":"13151","DOI":"10.1038\/s41598-017-13638-z","volume":"7","author":"M Strowitzki","year":"2017","unstructured":"Strowitzki M, Ritter A, Radhakrishnan P, Harnoss J, Opitz V, Biller M, Wehrmann J, Keppler U, Scheer J, Wallwiener M et al (2017) Pharmacological HIF-inhibition attenuates postoperative adhesion formation. Sci Rep 7(1):13151. https:\/\/doi.org\/10.1038\/s41598-017-13638-z","journal-title":"Sci Rep"},{"issue":"6","key":"2308_CR116","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1097\/xcs.0000000000000205","volume":"234","author":"M Biller","year":"2022","unstructured":"Biller M, Tuffs C, Bleul M, Tran D, Dupovac M, Keppler U, Harnoss J, Probst P, Schneider M, Strowitzki M (2022) Effect of metformin on HIF-1\u03b1 signaling and postoperative adhesion formation. J Am Coll Surg 234(6):1167\u20131180. https:\/\/doi.org\/10.1097\/xcs.0000000000000205","journal-title":"J Am Coll Surg"},{"issue":"6","key":"2308_CR117","doi-asserted-by":"publisher","first-page":"827","DOI":"10.5009\/gnl20367","volume":"15","author":"K Pinyopornpanish","year":"2021","unstructured":"Pinyopornpanish K, Leerapun A, Chattipakorn N (2021) Effects of metformin on hepatic steatosis in adults with nonalcoholic fatty liver disease and diabetes: insights from the cellular to patient levels. Gut and liver 15(6):827\u2013840. https:\/\/doi.org\/10.5009\/gnl20367","journal-title":"Gut and liver"},{"key":"2308_CR118","doi-asserted-by":"publisher","unstructured":"Huang Y, Wang X, Yan C, Li C, Zhang L, Liang E, Liu T, Mao J (2022) Effect of metformin on nonalcoholic fatty liver based on meta-analysis and network pharmacology. Medicine 101(43):e31437. https:\/\/doi.org\/10.1097\/md.0000000000031437","DOI":"10.1097\/md.0000000000031437"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-023-02308-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-023-02308-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-023-02308-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T08:03:43Z","timestamp":1683273823000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-023-02308-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,28]]},"references-count":118,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["2308"],"URL":"https:\/\/doi.org\/10.1007\/s00109-023-02308-5","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,28]]},"assertion":[{"value":"23 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consent to the publication of the article in Journal of Molecular Medicine.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}